BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.

Startup Ideas AI

15 Jun 2025
4.5/5
Rate this Tool
Featured
Promote this Startup
Copy Embedded Code

Have an awesome startup for founders?

Submit Startup
Feedback icon